Cosmos Health (NASDAQ:COSM) CEO Buys $137,931.12 in Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas purchased 766,284 shares of the stock in a transaction dated Wednesday, July 29th. The stock was bought at an average cost of $0.18 per share, with a total value of $137,931.12. Following the transaction, the chief executive officer owned 14,248,092 shares in the company, valued at $2,564,656.56. The trade was a 5.68% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Grigorios Siokas also recently made the following trade(s):

• On Thursday, July 30th, Grigorios Siokas purchased 349,825 shares of Cosmos Health stock. The stock was purchased at an average price of $0.20 per share, for a total transaction of $69,965.00.
• On Thursday, June 11th, Grigorios Siokas acquired 218,447 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.21 per share, for a total transaction of $45,873.87.
• On Wednesday, June 10th, Grigorios Siokas acquired 701,447 shares of Cosmos Health stock. The shares were purchased at an average price of $0.23 per share, with a total value of $161,332.81.

Cosmos Health Stock Up 7.7%

Shares of Cosmos Health stock opened at $0.22 on Friday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.92 and a current ratio of 1.08. The stock has a market capitalization of $12.94 million, a PE ratio of -0.34 and a beta of 4.83. Cosmos Health Inc. has a 52-week low of $0.16 and a 52-week high of $1.32. The company has a 50-day simple moving average of $0.23 and a two-hundred day simple moving average of $0.33.

Cosmos Health (NASDAQ:COSM) last issued its earnings results on Wednesday, May 20th. The company reported ($0.06) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.06). Cosmos Health had a negative net margin of 30.41% and a negative return on equity of 52.85%. The firm had revenue of $18.40 million for the quarter, compared to the consensus estimate of $17.93 million. On average, analysts anticipate that Cosmos Health Inc. will post 0.01 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised Cosmos Health from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Hedge Funds Weigh In On Cosmos Health

A number of institutional investors and hedge funds have recently modified their holdings of COSM. XTX Topco Ltd increased its position in Cosmos Health by 52.1% during the fourth quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock valued at $50,000 after acquiring an additional 34,117 shares during the last quarter. Renaissance Technologies LLC boosted its position in Cosmos Health by 16.7% in the first quarter. Renaissance Technologies LLC now owns 390,500 shares of the company’s stock worth $124,000 after purchasing an additional 55,925 shares during the last quarter. Finally, Citadel Advisors LLC boosted its position in Cosmos Health by 133.1% in the third quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock worth $250,000 after purchasing an additional 128,776 shares during the last quarter. 12.61% of the stock is currently owned by hedge funds and other institutional investors.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.